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Executive Summary 
The 2012 Massachusetts Department of Public Health’s (MDPH) Arbovirus Surveillance and Response 
plan provides surveillance and phased response guidance for both West Nile virus (WNV) and eastern 
equine encephalitis virus (EEE).  In the past ten years, there have been 68 cases of WNV infection 
reported in Massachusetts residents and sixteen human cases of EEE resulting in at least nine deaths. 
This plan reflects a comprehensive review of surveillance activities, mosquito control efforts, public 
information and risk communication related to arbovirus control in Massachusetts.  
 
The purpose of the plan is to provide guidance on operational aspects of surveillance and response by 
state and local agencies responsible for the prevention of mosquito-borne disease in the 2012 season. 
MDPH will continue to seek advice from its partners and collaborators and modify the plan, as 
appropriate. This document is open to continual review and evaluation. Information is provided to guide 
planning and actions to reduce the risk of human disease from EEE and WNV.   
 
Key components of the plan include:  
 
• monitoring trends in EEE and WNV activity in Massachusetts;  
• timely collection and dissemination of information on the distribution and intensity of WNV and EEE in 
the environment;  
• laboratory diagnosis of WNV and EEE cases in humans, horses and other animals;  
• effective communication, advice and support of activities that may reduce risk of infection;  
• phased response to provide measures to suppress the risk of infection. 
 
This document provides information about EEE and WNV disease and program goals, and specific 
guidelines for mosquito, equine and human surveillance.  Additionally, this document provides guidance 
for the dissemination of information, including routine information; media advisories of positive EEE and 
WNV findings in mosquitoes, as well as public health alerts related to positive EEE and WNV human 
cases.              
 
This plan describes MDPH’s public outreach efforts to provide helpful and accurate communication with 
Massachusetts’ residents about their risk from arboviral diseases and specific actions that individuals and 
communities can take to reduce this risk. 
 
I.   INTRODUCTION 
 
The Massachusetts Department of Public Health, in collaboration with the State Reclamation and 
Mosquito Control Board (SRMCB) and regional mosquito control projects (MCP), conducts surveillance 
for mosquito-borne viruses that pose a risk to human health. Surveillance currently focuses on West Nile 
and eastern equine encephalitis viruses, which are found in the local environment and are capable of 
causing serious illness and death in humans, horses and other mammals. 
 
The 2012 Massachusetts Surveillance and Response Plan for mosquito-borne diseases is based on a 
comprehensive plan initially developed for WNV in 2001 in collaboration with local health agencies, other 
state agencies, academic institutions, the Centers for Disease Control and Prevention (CDC), and 
interested groups and individuals. It incorporates components of the state’s EEE surveillance activities, 
which began in the 1950’s and have continued since that time. Monitoring for WNV began following a 
1999 outbreak of human WNV disease in the New York City area, the first known occurrence of this 
disease in North America. WNV was identified in birds and mosquitoes in Massachusetts during the 
summer of 2000 and has been found during each consecutive season.  
 
The updated 2012 plan is the result of analyses of surveillance data collected in Massachusetts and the 
United States. In order to address the complexity and seriousness of the human disease risk posed by 
EEE, MDPH convened a panel of experts in the fields of ecology, biology, public health, infectious 
disease and toxicology to review MDPH’s surveillance and response program and make 
recommendations for enhancing the program. In addition, MDPH continues to promote collaborative 
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efforts with multiple agencies and interest groups by seeking and accepting comment from stakeholders. 
The purpose of the plan is to provide guidance on operational aspects of surveillance and response by 
the state and local agencies with responsibilities for the prevention of mosquito-borne disease. MDPH will 
continue to seek advice from its partners and collaborators, and modify the plan, as appropriate. This 
document is open to continual review and evaluation, with changes made when there is opportunity for 
improvement.  
 
II. DISEASE HISTORY AND BACKGROUND 
 
The two principal mosquito-borne viruses (also known as arboviruses, for arthropod-borne viruses) 
recognized in Massachusetts, and known to cause human and animal disease are eastern equine 
encephalitis virus with the first human cases to have been identified in Massachusetts in 1938, and West 
Nile virus, with the first human case identified in the United States in 1999, and in Massachusetts in 2001.   
 
A. Eastern Equine Encephalitis Virus 
 
1. Background 
Eastern equine encephalitis is a serious disease which occurs sporadically in Massachusetts, with 30-
50% mortality and lifelong neurological disability among many survivors,. The first symptoms of EEE are 
fever (often 103º to106ºF), stiff neck, headache, and lack of energy. These symptoms show up three to 
ten days after a bite from an infected mosquito. Inflammation and swelling of the brain, called 
encephalitis, is the most dangerous and frequent serious complication. The disease gets worse quickly 
and some patients may go into a coma within a week. There is no treatment for EEE. In Massachusetts, 
approximately half of the people identified with EEE have died from the infection. People who survive this 
disease will often be permanently disabled. Few people recover completely.  
 
Historically, clusters of human cases have occurred over a period of 2-3 years, with a variable number of 
years between clusters. In the years between these case clusters or outbreaks, isolated cases can and 
do occur. Outbreaks of human EEE disease in Massachusetts occurred in 1938-39, 1955-56, 1972-74, 
1982-84, 1990-92, and, 2004-06. Two cases of EEE occurred in both 2010 and 2011; one case each year 
occurred in visitors to Massachusetts. 
 
Massachusetts Eastern Equine Encephalitis Experience 
Year(s) Human EEE Cases Human EEE Deaths 
1938-39 35 25 
1955-56 16 9 
1973-74 6 4 
1982-84 10 3 
1990-92 4 1 
2004-06 13 6 
2010 1 (plus 1 non-resident) 0 
2011 1  (plus 1 non-resident) 1 
 
The Public Health Service, in collaboration with MDPH, initiated a field surveillance program in 1957; 
following a 1955-56 outbreak of EEE. The purpose of the program was to gather data to guide prevention 
and risk reduction of this disease.. This program formed the basis for the Commonwealth’s current 
arbovirus program. 
 
2. Risk Factors for Disease Transmission 
Eastern equine encephalitis virus is an enzootic alphavirus found in some passerine (perching) bird 
species living in and around fresh-water swamp habitats. These habitats also support populations of the 
primary enzootic mosquito vector, Culiseta melanura, which feeds predominantly on birds. Although 
portions of the ecology of EEE virus have yet to be elucidated, the virus has a cycle of natural infection 
among bird populations with occasional ‘‘incidental” symptomatic infections in susceptible species 
including humans. The appearance of EEE in late June or early July coincides with the hatching of highly 
susceptible bird populations. The virus is circulated among the bird population by Cs. melanura and under 
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some circumstances Cs. morsitans, another bird-biting mosquito. Depending on when virus circulation 
begins, the size of the Culiseta populations, weather conditions, and probably additional, currently 
unidentified factors, this virus amplification cycle may eventually spill over and involve secondary, or 
"bridge", mosquito vectors that feed on both birds and mammals. In the Northeast these bridge vectors 
are mosquito species such as Coquillettidia perturbans, Ochlerotatus (formerly Aedes) canadensis, and 
Aedes vexans.  These bridge vectors are presumed to be responsible for the transfer of EEE to incidental 
hosts, including humans, horses llamas, alpacas, emus and ostriches.  The swamp habitats, which 
support large populations of Cs. melanura and are the initial source of EEE, are known as endemic foci.  
 
In the Northeast, these endemic foci are large hardwood swamps of mature white cedars and red maples.  
To grow in the permanently wet swamps, tree roots spread out across the peat soils characteristic of 
these habitats. These root systems create dark holes, or crypts, that are generally filled with water.. 
These crypts are the preferred ovipositing (egg-laying) sites for Cs. melanura and are where the larvae 
develop.  Culiseta melanura survives the winter in these crypts. The amount of rainfall during the summer 
and fall affects the survival of the larvae during the winter and, in part, determines the population of adult 
mosquitoes the following year.    
 
The risk of EEE infection in humans varies by geographical area in Massachusetts, as well as in the 
United States, and is correlated with the location of the necessary swamp habitats. In Massachusetts, 
these areas are most common in southeastern Massachusetts. The majority of EEE cases have occurred 
in Norfolk, Bristol, and Plymouth counties with some cases also occurring in Middlesex County. A very 
few cases have also occurred in Essex County and even more rarely in Worcester County or further west. 
Historically, Barnstable and the Islands of Martha’s Vineyard and Nantucket have not had human cases 
of EEE. 
 
Currently, it is impossible to predict, with complete accuracy, the appearance of EEE and the probability 
of human EEE infection in any given year.  However, over 50 years of surveillance for EEE in 
Massachusetts has enabled the development of a mosquito-based, EEE surveillance system and the 
identification of several factors that help provide an estimate of human risk. These estimates are used to 
alert the residents of the state and guide mosquito control activities. Risk estimates are based on the 
current level of EEE activity in both enzootic (bird-biting) and epizootic (mammal-biting) vectors, 
population levels of these mosquito species, recent and historic levels of EEE activity, timing of virus 
identification in bird-biting and mammal-biting mosquitoes, and prevailing weather conditions.   
 
Temporally and spatially associated human cases are more likely when multiple factors indicate that risk 
is increasing. Identification of EEE in the enzootic mosquito vector, Cs melanura, is useful for determining 
areas of virus amplification and as a proxy measure of the amount of EEE virus in the environment. 
Theoretically, the more virus that is circulating between mosquitoes and birds, the more likely it will be to 
be picked up by a bridge vector mosquito and transmitted to humans. The intensity of enzootic EEE 
transmission correlates with the abundance of the enzootic vector, Cs melanura. Abundant populations of 
this species provide greater opportunity for the virus to perpetuate or amplify within the bird population. 
Identification of EEE in bridge vector mosquito species confirms the presence of infected mosquitoes of a 
species known to feed on humans. The more virus that has spilled over into bridge vector species, the 
greater the chance that a person will be exposed to the virus. Warm temperatures increase the rate of 
both mosquito development and virus replication within mosquitoes. Consistently elevated temperatures 
increase mosquito populations of all species, speed up virus multiplication within mosquitoes, and 
therefore act to increase the amount of virus in the environment overall. 
 
Other factors that affect the risk of EEE infection for humans are the abundance of specific kinds of 
mosquitoes at critical periods of the transmission season, groundwater levels, and the timing of rainfall 
and flooding during the mosquito season. Long-term weather patterns during the fall and winter that 
produce high ground water levels and snow cover may enhance survival of Cs. melanura larval 
populations. The abundance of these larval populations may serve as an early indicator of the potential 
for human disease later in the year. 
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Multiple factors affect the development, survival, and abundance of mosquitoes. It is not currently 
possible to predict either the abundance of mosquitoes or the risks for encountering an infected vector 
later in the season.  
 
B. West Nile Virus 
 
1. Background                                                                                                                                                                           
West Nile virus (WNV) first appeared in the United States in 1999. Since the initial outbreak in New York 
City, the virus has spread across the US from east to west. WNV infection may be asymptomatic in some 
people, but it leads to morbidity and mortality in others.  WNV causes sporadic disease of humans, and 
occasionally significant outbreaks. Nationally, 667 human cases of WNV neuroinvasive disease 
(meningitis and encephalitis) and WNV fever were reported to the CDC in 2011.    
 
The majority of people who are infected with WNV (approximately 80%) will have no symptoms. A 
smaller proportion of people who become infected (~ 20%) will have symptoms such as fever, 
headache, body aches, nausea, vomiting, and sometimes swollen lymph glands. They may also 
develop a skin rash on the chest, stomach and back. Less than 1% of people infected with WNV will 
develop severe illness, including encephalitis or meningitis. The symptoms of severe illness can 
include high fever, headache, neck stiffness, stupor, disorientation, coma, tremors, convulsions, 
muscle weakness, vision loss, numbness and paralysis. Persons older than 50 years of age have a 
higher risk of developing severe illness. In Massachusetts, there were at least five fatal WNV human 
cases identified between 2002-2011, All fatalities were in individuals eighty years of age or older. 
                                                                                                                                                                                                  
Following the identification of WNV in birds and mosquitoes in Massachusetts during the summer of 
2000, MDPH arranged meetings between local, state and federal officials, academicians and the public to 
develop recommendations to adapt the arbovirus surveillance and response plan to include activities 
appropriate for WNV. Four workgroups addressed the issues of surveillance, risk reduction interventions, 
pesticide toxicity and communication. 
 
2. Risk Factors for Disease Transmission 
West Nile virus is amplified by a cycle of continuous transmission between mosquito vectors and bird 
reservoir hosts. Infected mosquitoes carry virus and transmit it to susceptible bird species. WNV infection 
can be fatal in some species of birds, particularly American crows and blue jays (corvids). Confirmation of 
WNV in dead birds historically provided sentinel information used for assessing the risk of human WNV 
infections. However, the proportion of susceptible birds has decreased over time so that testing dead 
birds for the presence of virus is no longer an efficient surveillance tool. 
 
The principal mosquito vectors for West Nile virus on the East Coast are members of the genus Culex, 
primarily C. pipiens and C restuans. These species may be abundant in urban areas, breeding easily in 
artificial containers such as birdbaths, discarded tires, buckets, clogged gutters, catch basins and other 
standing water sources. Both species feed mainly on birds and occasionally on mammals, including 
humans. Peak feeding activity for these species occurs from dusk into the late evening. Consistently high 
temperatures and lower precipitation rates are factors that have been associated with higher mosquito 
infection and human illness rates. Additionally, warmer winter temperature conditions may result in larger 
numbers of Culex species overwintering as adult, with resulting increases in early season Culex 
abundance. 
   
There are additional mosquito species in Massachusetts that can be involved in the transmission of WNV 
to humans. Culex salinarius lives in brackish and freshwater wetlands and feeds on amphibians, birds, 
and mammals; it is well known for biting humans. Ochlerotatus japonicus may be involved in the 
transmission of both WNV and EEE. This species utilizes natural and artificial containers such as tires 
and rock pools as larval habitat. It feeds mainly on mammals and is a fierce human biter. 
 
West Nile virus activity varies from year to year. When a large number of infected birds and a high rate of 
infected mosquitoes occur in a relatively small geographic area, the risk of transmission of virus to 
humans is increased. In addition, there is evidence that when meteorologic conditions are such that Cx. 
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restuans populations are increased relative to Cx. pipiens, the risk of transmission to humans may be 
increased. Surveillance evidence indicates that WNV is established in the United States and that virus 
activity is likely to occur annually. 
 
 A summary of current and historical surveillance information for EEE and WNV in Massachusetts is 
available online at www.mass.gov/dph/wnv. 
 
C. Other viruses 
 
Although testing for other arboviruses is not routine, MDPH is prepared to rapidly implement screening for 
other relevant viruses carried by mosquitoes that may impact human health. These agents include 
dengue and chikungunya viruses, for example. Decisions to implement surveillance for new viruses will 
be based on information pertaining to new or unusual activity and/or local environmental detection of 
mosquito vectors that support new viral agents.  This is part of an ongoing risk assessment performed by 
MDPH and CDC’s Arbovirus Surveillance Network. 
 
III. PROGRAM GOALS 
 
Timely and accurate information based on surveillance information is used to provide an estimate of the 
level of risk for human disease from WNV and EEE. Based on this surveillance information, plans and 
actions to reduce risk can be developed and implemented when needed. Program activities include: 
 
• Testing mosquitoes, horses, humans and other appropriate animals to identify EEE and WNV 
infections; 
• Tracking trends in incidence and prevalence of EEE and WNV infections by geographic area; 
• Estimating viral infection rates in mosquitoes; 
• Stratification of risk by geographic areas as a function of relative risk of human disease;  
• Conducting surveillance for human and animal disease; 
• Educating human and animal medical practitioners on the appropriate procedures for detecting 
infections and disease caused by mosquito-borne viruses; 
• Recommending measures to reduce virus transmission and disease risk; 
• Educating the public on mosquito-borne diseases and disease risk, and common-sense 
precautions to reduce the risk of infection; and 
• Participating in the national Arbovirus Surveillance Network. 
 
IV. AGENCY ROLES 
 
A. Massachusetts Department of Public Health (MDPH)  
 
The central purpose of arbovirus surveillance is to provide information that will guide planning and 
activities to reduce the risk of human disease from EEE and WNV infection. To achieve this, the main 
objectives are to monitor trends in EEE and WNV in Massachusetts; provide timely information on the 
distribution and intensity of WNV and EEE activity in the environment; perform laboratory diagnosis of 
WNV and EEE cases in humans, horses and other animals; communicate effectively with officials and the 
public; provide guidelines, advice and support on activities that effectively reduce risk for disease; and 
provide information on the safety, anticipated benefits and potential adverse effects of proposed 
prevention interventions. 
 
MDPH works cooperatively with the SRMCB, regional mosquito control projects and other agencies to 
collectively identify and support the use of safe and effective mosquito control measures based on 
integrated pest management (IPM) principles. The use of pesticides as a means to reduce human risk is 
one of several methods/strategies.  
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B. State Reclamation and Mosquito Control Board (SRMCB) 
 
The SRMCB oversees mosquito control programs and activities in the Commonwealth of 
Massachusetts. The SRMCB consists of three (3) members representing the Department of Agricultural 
Resources (DAR), Department of Conservation and Recreation (DCR), and Department of Environmental 
Protection (DEP).  Additionally, the SRMCB advises its respective state agency Commissioners on 
actions to reduce mosquito populations based on MDPH findings and characterization of risk.   
 
The SRMCB’s ‘Operational Response Plan to Reduce the Risk of Mosquito-Borne Disease in 
Massachusetts’ addresses the issues related to the operational aspects of adult mosquito surveillance 
and control to prevent and/or reduce the risk of mosquito-borne diseases. The plan may be viewed online 
at www.mass.gov/agr/mosquito/arbovirus.htm. 
 
In 2006, the SRMCB created a SRMCB Mosquito Advisory Group (MAG). The MAG is composed of 
scientific experts from the fields of medical entomology, infectious disease, and mosquito control,  and 
provides independent scientific advice to the SRMCB to assist them in evaluating and assessing data 
from both MDPH and mosquito control projects. 
 
C. Mosquito Control Projects (MCPs) 
 
There are nine (9) organized Mosquito Control Projects or Districts located throughout Massachusetts.  
All of the mosquito control activities of these organized agencies are performed under the aegis of the 
SRMCB. MCPs collaborate with local boards of health in their jurisdictions to control mosquitoes. These 
locally authorized efforts employ a variety of targeted activities for source reduction, larviciding and 
adulticiding that are in compliance with the SRMCB Operational Response plan. Additional details relating 
to control strategies may be found within the SRMCB Operational Plan. 
 
 
V. SURVEILLANCE  
 
A. Massachusetts Department of Public Health 
 
Surveillance of mosquitoes for arboviruses is a core function of MDPH. Monitoring mosquitoes for the 
presence of virus provides an estimate of risk to humans. Massachusetts has a long-term field 
surveillance program that was initiated in 1957 for EEE and was enhanced in 2000 to include WNV 
surveillance. The extensive experience in Massachusetts with surveillance for mosquito-borne disease 
provides expertise and capacity to guide risk reduction efforts. MDPH uses a comprehensive and flexible 
strategy that modifies certain surveillance activities in response to trends in disease risk.  
 
On an ongoing basis, MDPH monitors national and regional surveillance data and current scientific 
literature to assess risk of newly emerging arboviruses in Massachusetts. In addition, defined subsets of 
mosquito pools will be tested for the presence of new or emerging viruses 
 
1. Fixed and Long-Term Trap Sites   
MDPH field staff collect mosquitoes from areas with activity during the previous year, and from long-term 
trap sites maintained in the EEE high-risk areas of southeastern and eastern Massachusetts (Figure 1). 
Trapping of gravid mosquitoes for WNV testing is conducted both by MCPs and MDPH field staff at 
various locations throughout the state during the arbovirus season. At the William A. Hinton State 
Laboratory Institute (HSLI), MDPH tests samples (pooled sets of 10- 50 mosquitoes) for WNV and EEE. 
Test results from routine mosquito collections are available within 24 hours after delivery of mosquitoes to 
HSLI. Fixed and long-term trap sites provide the best available baseline information for detecting trends in 
mosquito abundance and virus prevalence, and for estimating the relative risk of human infection from 
EEE virus and WNV. MDPH field staff monitor larvae from select sites in late fall and early spring to 
determine end-season and pre-season larval abundance. Informal monitoring of larval abundance from 
these sites continues on a weekly basis during the arbovirus season.  
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2. Supplemental Trap Sites  
When EEE or WNV activity is detected in an area, additional trap sites and/or trap types are used 
to obtain more information regarding the intensity of virus activity in mosquitoes. The following 
risk indicators may result in the implementation of more intensive mosquito trapping: 1) virus 
isolations in mosquitoes; 2) emergence of large numbers of human-biting mosquitoes in an area 
with a high rate of virus activity and 3) identification of human or animal cases. 
 
3. Mosquito Control Project Trap Sites   
Massachusetts Mosquito Control Projects (MCPs), use a variety of available control strategies to 
impact mosquito abundance. Monitoring mosquito abundance is accomplished through various 
surveillance methods including but not limited to larval dip counts and the use of light/ CO2 
baited traps and gravid traps.  
 
B.  Avian Surveillance 
 
MDPH discontinued avian surveillance for WNV as of April, 2009. When the virus was first introduced into 
the United States, WNV caused high mortality rates in certain species of birds, particularly corvids, thus 
reporting and testing of dead birds was a productive way to detect and monitor WNV activity in an area. 
However, in recent years, the tracking and testing of dead birds has become significantly less useful as a 
surveillance tool. Monitoring mosquitoes for presence of virus is the primary predictive indicator of human 
arbovirus disease risk. Therefore, the routine laboratory testing of dead wild birds for West Nile virus 
(WNV) has been eliminated. This is consistent with recent policy changes in multiple states.  
 
Most birds that are infected with EEE virus survive the viremia, making individual dead bird EEE 
monitoring impractical. Non-native bird species such as emus, ostriches and exotic game birds 
are highly susceptible to EEE and infections within farmed flocks have occurred in 
Massachusetts. Testing of highly suspect bird specimens for EEE and/or WNV infection is done 
on an as-needed basis as determined by MDPH. 
 
A  24/7 information line (1-866-MassWNV) is maintained during the arbovirus season. Callers receive 
recorded messages that provide information on why birds are no longer tested, information on WNV/EEE 
disease and instructions for proper disposal of dead birds. More detailed information on this topic is 
available on the MDPH website. 
 
C.  Animal Surveillance  
 
Specimens from horses and other domestic animals that have severe neurological disease suspected of 
being caused by EEE or WNV infection are tested at SLI. Testing may take up to nine working days to 
complete. Veterinarians, DAR, the United States Department of Agriculture (USDA) and Tufts University 
Cummings School of Veterinary Medicine collaborate with MDPH to identify and report suspect animal 
cases. In addition, blood and/or tissue samples from animals from other sources, such as zoos, horse 
stables or the wild are tested, as appropriate. Current information on WNV and EEE infections in horses, 
along with clinical specimen submission procedures, are disseminated to large animal veterinarians, 
stable owners and others through various distribution methods and are posted on the MDPH arbovirus 
website at www.mass.gov/dph/wnv. Horses and other animals can be immunized against infection with 
WNV and EEE with available veterinary vaccines. Vaccination is the primary means of preventing 
infection in animals.  
 
D. Human Surveillance 
 
1. Routine surveillance  
Specimens from human cases of encephalitis and meningoencephalitis are submitted to MDPH and 
screened for WNV and EEE. Testing may take up three to seven days to complete. Occasionally, testing 
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cannot be completed at HSLI and samples are forwarded to the Centers for Disease Control and 
Prevention (CDC) for additional testing. Time to receipt of final results from CDC is variable. Current 
information on WNV and EEE infections in humans, along with clinical specimen submission procedures, 
are disseminated to physicians (infectious disease, emergency medicine and primary care), emergency 
department directors and hospital infection control practitioners through various distribution methods and 
are posted on the MDPH arbovirus website at www.mass.gov/dph/wnv. 
 
2. Active surveillance  
If surveillance data estimate a high risk of human disease, active surveillance may be instituted in 
targeted areas. Active surveillance involves regularly contacting local health care facilities to 
communicate current surveillance information, promoting disease prevention strategies, reviewing 
specimen submission procedures and highlight the need for testing patients presenting with signs and 
symptoms possibly representing infection with EEE virus or WNV. The Health and Homeland Alert 
Network (HHAN), a secure electronic alerting system, is used to send information to local boards of health 
upon confirmation of EEE or WNV in any specimen. 
 
3. Pesticide related surveillance  
Outreach on pesticide illness reporting is coordinated by the MDPH’s Bureau of Environmental Health. In 
the event of an aerial pesticide application, active surveillance efforts will be implemented with emergency 
departments and intensified outreach efforts will be made to health care providers. 
 
VI. Communication of Surveillance Information 
 
MDPH works with the SRMCB and MCPs to identify and support the use of risk reduction and disease 
prevention methods that are specific to the causes of disease, and supports planning and practices which 
incorporate the most appropriate prevention methods. Additionally, MDPH routinely communicates with 
health agencies in neighboring states to share relevant arbovirus findings. 
 
Prior to the beginning of the arbovirus season, general disease information and specimen submission 
procedures are provided to local boards of health via the HHAN. The local boards of health (LBOH) are 
asked to provide routine and emergency contact information for a primary and secondary arbovirus 
contact during the season. Although routine surveillance specimen notifications are scheduled during 
normal business hours, test results sometimes become available after hours. General information and 
fact sheets are posted on the MDPH arbovirus website and are available publicly. 
 
Laboratory confirmation of a human WNV or EEE case is immediately reported by telephone to the 
submitting physician, and LBOH in the town where the case resides. If the LBOH cannot be reached via 
telephone in a timely manner, a severe level HHAN alert is sent.  
 
Laboratory confirmation of WNV or EEE in a veterinary specimen is immediately reported by telephone to 
the submitting veterinarian, the DAR Division of Animal Health, and the LBOH. If the LBOH cannot be 
reached via telephone in a timely manner, a severe level HHAN alert is sent.  
 
Initial identification of virus in mosquitoes from a given town is reported to the LBOH and MCP by 
telephone.  Adjacent towns are notified via a moderate level HHAN alert. In order to encourage risk 
communication on a larger focal area level rather than a city/town level, all subsequent positive findings in 
mosquitoes are reported once daily to all affected towns and adjacent towns, via a moderate level HHAN 
alert. All subsequent positive mosquito findings will be reported once daily to all MCPs and the SRMCB. 
 
The MDPH Regional Health Office (RHO) in the area will offer assistance with local response. All 
laboratory confirmed results for WNV and EEE in humans, veterinary specimens, and mosquitoes are 
provided to the RHO, MCPs and members of the SRMCB once the LBOH has been notified. 
 
At the time of notification, MDPH encourages LBOH to share the information with other local agencies 
and high-risk populations in their community, as appropriate. MDPH provides LBOH with sample press 
releases for their use. Depending on the circumstances, MDPH may also issue a public health alert. In 
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addition, weekly summaries of results from mosquito samples submitted and tested will be posted by 
town as News Items on the HHAN.  
 
After all appropriate individuals and agencies have been notified, positive surveillance findings are made 
available to the media and general public on the MDPH Arbovirus website at www.mass.gov/dph/wnv. 
This website, which also includes links to a variety of educational materials related to mosquito-borne 
diseases, is updated on a daily basis throughout the arbovirus season. Results are also reported to the 
CDC’s ArboNET reporting system.  
 
MDPH issues public health alerts through the media when surveillance information indicates an 
increased risk of human disease or if a significant surveillance event occurs (for example, the first 
arbovirus activity of the season). In general, alerts include current surveillance information and 
emphasize prevention strategies. 
 
VII. Prevention and Response: Recommendations for Phased Response to Surveillance Data 
 
The guidance provided here is based on current knowledge of risk for human disease, and 
appropriateness and efficacy of interventions available to reduce that risk. Multiple factors 
contribute to the risk for mosquito-transmitted human disease. Decisions about risk reduction 
measures should be made after consideration of surveillance information.  
 
Public awareness of what can be done to reduce risk of infection is of utmost importance. Typically, risk 
for any individual is expected to be relatively low, and the routine precautions taken by individuals may be 
sufficient to reduce opportunities for infection. Routine precautions should include: 
• avoiding outdoor activity in areas and during times of day with increased mosquito activity; 
• use of mosquito repellents containing and FDA-approved active ingredient; and 
• use of clothing to reduce mosquito access to skin and 
• avoiding outdoor activity in areas and during times of day with increased mosquito activity. 
These personal protective measures must form the basis of all risk reduction and the need to utilize them 
is not alleviated by any mosquito control activities. Risk for mosquito-borne disease persists until the first 
local hard frost kills all remaining adult mosquitoes. 
 
When multiple factors that indicate an increased risk for transmission to humans are present, additional 
risk reduction measures may be necessary. These guidelines take into consideration the complexity of 
reducing risk of human disease from EEE and WNV infection, and form a framework for decision-making 
by both individuals and agencies.  
 
General guidelines are provided for an array of situations as noted in the Surveillance and Response Plan 
tables that follow. Specific situations must be evaluated individually and options discussed before actions 
are taking. Estimating risk from mosquito-borne disease(s) is complex and many factors modify specific 
risk factors. MDPH assesses risk and works with LBOH, MCPs, and the SRMCB to develop the most 
appropriate response activities to reduce the risk of human disease. There is no single indicator that can 
provide a precise measure of risk, and no single action that can completely assure prevention of infection. 
 
MDPH works collaboratively with other state agencies, the SRMCB and MCPs to collectively identify and 
support the use of safe and effective mosquito control measures based on integrated pest management 
(IPM) principles.  
 
A. MDPH Guidance  
 
MDPH uses data from arbovirus surveillance to assess human risk levels as outlined in the phased 
response tables of this plan. Risk levels are defined for "focal areas". Focal areas may incorporate 
multiple communities, towns or cities, and parts thereof. Factors considered in the estimation of human 
risk in a focal area include: mosquito habitat, prior virus isolations, human population densities, timing of 
recent isolations of virus in mosquitoes, current and predicted weather patterns and seasonal conditions 
needed to present risk of human disease.  
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If the risk for multiple human infections becomes widespread and involves multiple jurisdictions, MDPH 
will convene the SRMCB, MCPs, and MAG to get their recommendation for appropriate mosquito control 
interventions to reduce public health risk. The SRMCB will provide recommendations on appropriate 
pesticide(s), route and means of treatment for the specific treatment areas. Interventions may include 
state-funded aerial application of mosquito adulticide. Assessment of the need for and utility of, a focal or 
large-scale aerial application of mosquito adulticide includes evaluating evidence that the seasonal and 
biological conditions present a persistent risk of human disease, and that those same conditions permit 
the effective use of an aerially applied pesticide. 
 
B. Risk Reduction and Prevention Guidance for Seasons with Indicators of Increased EEE Risk 
 
Based on historical experience with EEE, MDPH has identified specific critical indicators for overall EEE, 
risk, and provides specific risk reduction and prevention guidance for seasons with an anticipated 
increased EEE risk. Activities that may be undertaken in response to indicators of increased risk include: 
 
• MDPH may release public health alerts throughout the season to remind the public of the steps to 
take to reduce their risk of exposure to mosquitoes. 
• Local municipalities may be encouraged to reschedule outdoor evening events to avoid the period 
between dusk and dawn which correspond to peak mosquito activity. 
• MCPs may increase their source reduction activities to reduce mosquito-breeding habitats and to 
reduce adult mosquito abundance. This may include ground and aerial larviciding. 
• After sustained findings of positive mosquito isolates, if not already in progress, adult mosquito 
control efforts including targeted ground adulticiding operations should be considered. The decision to 
use ground-based adult mosquito control will depend on critical modifying variables including the time 
of year, mosquito population abundance and proximity of virus activity to at-risk populations.  
• Other intensified efforts may be implemented following coordination between MDPH and other 
agencies including DEP, DAR, and DCR. 
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Aerial Adulticide Application in Response to Mosquito-Borne Disease Threat 
2012 Multi-Agency Response Flowchart 
 
 
1. Determination of Response  
• When human risk is elevated to a high level of concern as indicated by the MDPH Surveillance 
and Response Plan; DPH will determine, in consultation with Mosquito Control Projects, 
SRMCB and the Mosquito Advisory Group whether aerial application is warranted.  
 
 
2. Characterization of Area of Risk 
• Once consensus is obtained, DPH characterizes the area of risk and delineates the perimeter of the 
spray area based on mosquito and virus surveillance. 
• DPH/BID provides the GIS perimeter map to inter-agency collaborators as soon as possible. 
 
 
3. Commissioner Certification 
• DPH/BID requests that the Commissioner of Public Health issue a “Certification that Pesticide 
Application is Necessary to Protect Public Health”  
 
 
 
Action Items 4a-4c Occur Simultaneously: 
 
4a. Determination of Appropriate Pesticide 
• Prior to July 1 of each season, DPH/BEH and DAR will determine the type of pesticide to be 
used in the event that an aerial application will be warranted and obtain any EPA pesticide 
waivers, if necessary, for use in aerial application.  
• In the event that aerial application is warranted, DPH/BEH and DAR will confirm this selected 
pesticide for use. 
 
 
4b.Determination of No-Spray Zones 
• Aerial no-spray zones (mosquito treatment sensitive areas data layers) defined: 
1)Certified organic farms 
2)Priority habitats for federally listed  endangered and threatened  species  
3)Surface water supply resource areas 
4)Commercial fish hatcheries/aquaculture 
• DAR reviews any emergency waivers needed to use pesticides on school property and ensure 
compliance with pesticide laws.  
• DAR/SRMCB will submit a ‘Notice of Intent’ to EPA to obtain an NPDES permit within 30 
days of the aerial adulticide event. 
 
 
4c.Exclusion/Inclusion of Priority Habitats: 
• DPH will determine, in consultation with  SRMCB, DAR, DEP, and DFW  if spraying in 
mosquito treatment sensitive areas is necessary to protect the public health.  
• If spraying in these areas is necessary to reduce the risk to public health then: 
o DPH requests a permit from DFW be issued to DAR for taking endangered, threatened, 
or special concern species. 
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5. Preparation of Final GIS Data Map  
• DAR coordinates compilation of mosquito treatment sensitive areas data layers (no-spray zones) 
developed by DAR, DFW, and DEP within designated DPH spray area into a final map. 
 
 
 
6. Environmental Monitoring 
• DEP, DAR, and DPH/BEH notify partner environmental agency collaborators of planned 
environmental monitoring to provide opportunity for input/collaboration.  
     DEP, DAR, and DPH/(BEH/BLS) initiate plans for pre/post-monitoring for public drinking water 
reservoirs, honey bees, macro-invertebrates, and cranberries in designated spray area. 
 
7. Emergency Room and Poison Control Contacts 
• DPH/BEH contacts and provides pesticide illness surveillance protocols to emergency 
departments, poison control centers, and local health departments. 
 
 
 
8. Notification of Date & Time of Application 
• DAR and DPH provide public notices regarding the locations, dates, and times of aerial spraying. 
• DAR will maintain a website with GIS maps of the aerial spray area and will update this site 
daily during spray operations. 
• DPH will provide recorded hotline information regarding the spray zone, precautionary 
measures, and telephone numbers to report fish kills or other environmental impacts. 
 
 
 
9. Operational Procedures-Aerial Application 
• DAR/SRMCB initiates aerial spray operations using collective guidance and consensus 
developed through multi-agency, cross secretariat process.  
• The aerial application operational procedures are followed as described in the SRMCB 
Operational Response Plan. 
 
 
 
 
DPH- Department of Public Health 
BID- Bureau of Infectious Diseases 
BEH- Bureau of Environmental Health 
BLS- Bureau of Laboratory Sciences  
 
DAR- Department of Agricultural Resources 
SRMCB- State Reclamation and Mosquito Control Board 
DFG-Department of Fish and Game 
DFW- Division of Fisheries and Wildlife  
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Table 1.  Guidelines for Phased Response to WNV Surveillance Data  
 
Risk 
Category 
Probability of 
locally acquired 
human disease 
Definition of Risk Category for a Focal Area1 
 
Recommended Response  
1 Remote All of the following conditions must be met: 
 
Prior Year 
No prior year WNV activity detected in the focal 
area. 
And 
 
Current Year 
No current surveillance findings indicating WNV 
activity in mosquitoes in the focal area                  
 
And 
 
No animal or human cases. 
 
 
 
1. MDPH staff provides educational materials and 
clinical specimen submission protocols to targeted 
groups involved in arbovirus surveillance, including, but 
not limited to, local boards of health, physicians, 
veterinarians, animal control officers, and stable 
owners. 
 
2. Educational efforts directed to the general public on 
personal prevention steps and source reduction, 
particularly to those populations at higher risk for 
severe disease (e.g., the elderly). 
 
3. MDPH provides recorded information on WNV/EEE 
disease, and disposal of dead birds via MDPH WNV 
information line (1-866-MASS-WNV). 
 
4. Assess mosquito populations, monitor larval and 
adult mosquito density.  
 
5. Routine collection and testing of mosquitoes. 
 
6. Initiate source reduction; use larvicides at specific 
sites identified by entomologic survey. In making a 
decision to use larvicide consider the abundance of 
Culex larvae, intensity of prior virus activity and 
weather. 
 
7.  Locally determined, standard, adult mosquito control 
activities are implemented.  No specific supplemental 
control efforts are recommended. 
 
8. Passive human and horse surveillance. 
 
9.  Emphasize the need for schools to comply with MA 
requirements for filing outdoor IPM plans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
1 Focal Area- May incorporate multiple communities, towns or cities, or parts thereof. Factors considered in 
determination of  human risk in a focal area include mosquito habitat, prior isolations, human population densities, 
timing of current isolations of virus in mosquitoes, weather patterns,  time of season conditions needed to present 
risk of human disease  
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2 Low Prior Year 
Any WNV activity in mosquitoes in the 
community or focal area 
 
Or 
 
Current Year 
1. Sporadic WNV activity in mosquitoes in the 
focal area.  
And 
 
2. No animal or human cases  
 
Definitions: 
Sporadic WNV activity- when 1-2 mosquito 
isolates are detected during non-consecutive 
weeks within one focal area. 
 
Sustained WNV activity- when mosquito isolates 
are detected for 2 or more consecutive weeks 
within one focal area.  
 
 
Response as in category 1, plus:  
  
1. Expand community outreach and public education 
programs, particularly among high-risk populations, 
focused on risk potential and personal protection, 
emphasizing source reduction.   
 
2.  Increase larval control and source reduction 
measures. 
 
3. Public health alert sent out by MDPH in response to 
first WNV virus positive mosquito pool detected during 
the season. The alert will summarize current 
surveillance information and emphasize personal 
prevention strategies. 
 
4. Locally determined standard adult mosquito control 
activities continue. 
 
 
3 Moderate Prior Year       
Confirmation of one or more human or animal 
WNV cases; or sustained WNV activity in 
mosquitoes for 2 or more weeks. 
 
Or 
 
Current year                                            
1. Sustained WNV activity or multiple isolations 
during the same week plus at least one multiple 
meteorological or ecological conditions (such as 
above average temperatures, dry conditions, or 
larval abundance) associated with increased 
abundance and increased risk of human 
disease.    
 
 
And 
 
3. No animal or human WNV cases                         
 
Response as in category 2, plus: 
 
1. Outreach and public health educational efforts are 
intensified including media alerts as needed. 
 
 2. If not already in progress, standard, locally 
determined adult mosquito control efforts including 
targeted ground adulticiding operations should be 
considered against Culex mosquitoes and other 
potential vectors, as appropriate. The decision to use 
ground-based adult mosquito control will depend on 
critical modifying variables including the time of year, 
mosquito population abundance and proximity of virus 
activity to at-risk populations.  
 
3. Duly authorized local officials may request that DPH 
Commissioner issue a certification that pesticide 
application is necessary to protect public health in 
order to preempt homeowner private property no-spray 
requests. 
 
4. Supplemental mosquito trapping and testing may be 
performed in areas with positive WNV findings.  
  
5. Local boards of health are contacted via phone or 
HHAN (Health and Homeland Alert Network) upon 
confirmation of WNV in any specimen. Advise health 
care facilities of increased risk status and 
corresponding need to send specimens to SLI for 
testing. 
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4 High Current Year 
1. Sustained or increasing WNV activity in 
mosquitoes plus multiple meteorological or 
ecological conditions (such as above average 
temperatures, dry conditions, increased larval 
abundance) associated with elevated mosquito 
abundance; and increasing minimum infection 
rates.    
 
And/or 
 
2. MDPH confirmation of WNV in an animal at 
any time 
 
And/ or, 
 
3. MDPH confirmation of WNV in a human at any 
time 
 Response as in category 3, plus:  
 
1. Intensify public education on personal protection 
measures including avoiding outdoor activity during 
peak mosquito hours, wearing appropriate clothing, 
using repellents and source reduction. 
a. Utilize multimedia messages including public health 
alerts from MDPH, press releases from local boards of 
health, local newspaper articles, cable channel 
interviews, etc. 
b.  Encourage local boards of health to actively seek 
out high-risk populations in their communities (nursing 
homes, schools, etc.) and educate them on personal 
protection  
 d.  Advisory information on pesticides provided by 
MDPH Bureau of Environmental Health.                           
e. Urge towns and schools to consider rescheduling 
outdoor events. 
 
2. Intensify and expand active surveillance for human 
cases. 
   
3. Intensify larviciding and/or adulticiding control 
measures where surveillance indicates human risk. 
Local, ground- based ULV applications of adulticide 
may be repeated as necessary to achieve adequate 
mosquito control. Town or city may request preemption 
of homeowner private property no-spray requests. 
 
4. Local officials should evaluate all quantitative 
indicators including population density and time of year 
and may proceed with focal area aerial adulticiding. 
 
5. Duly authorized local officials may request that the 
DPH Commissioner issue a certification that pesticide 
application is necessary to protect public health in 
order to preempt homeowner private property no-spray 
requests. 
 
6. MDPH will confer with local health officials, SRMCB 
and Mosquito Control Projects to determine if the risk 
of disease transmission threatens to cause multiple 
human cases and warrants classification as level 5. 
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5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Critical  Current Year 
1. More than 1 confirmed human or animal case 
in a community or focal area 
 
Or  
 
2. Multiple quantitative measures indicating 
critical risk of human infection (e.g. early season 
positive surveillance indicators, and sustained  
elevated field mosquito infection rates, and horse 
or mammal cases indicating escalating epizootic 
activity)   
 
 
 
Response as in category 4, plus: 
1. Continued highly intensified public outreach 
messages on personal protective measures. Frequent 
media updates and intensified community level 
education an outreach efforts. 
2. MDPH will confer with local health agencies, 
SRMCB and Mosquito Control Projects to discuss the 
use of intensive mosquito control methods and 
determine if measures need to be taken by the 
agencies to allow for and assure that the most 
appropriate mosquito control interventions are applied 
to reduce risk of human infection. These interventions 
may include state-funded aerial application of mosquito 
adulticide. 
 
Factors to be considered in making this decision 
include the seasonal and biological conditions needed 
to present a continuing high risk of WNV human 
disease and that those same conditions permit the 
effective use of an aerially applied pesticide. 
 
Once critical human risk has been identified, the 
SRMCB will determine the adulticide activities that 
should be implemented in response to identified risk by 
making recommendations on: 
 
A. Appropriate pesticide 
B. Extent, route and means of treatment 
C. Targeted treatment areas  
 
3. MDPH Bureau of Environmental Health will initiate 
active surveillance via emergency departments and 
with health care provides only if aerial spraying 
commences. 
 
4. MDPH will designate high-risk areas where it has 
issued a certification that pesticide application is 
necessary to protect public health in order to preempt 
homeowner private property no-spray requests. 
If this becomes necessary, notification will be given to 
the public.  
 
5. MDPH recommends restriction of group outdoor 
activities, during peak mosquito activity hours, in areas 
of intensive virus activity. 
 
6. MDPH will communicate with health care providers 
in the affected area regarding surveillance findings and 
encourage prompt sample submission from all clinically 
suspect cases. 
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Table 2.  Guidelines for Phased Response to EEE Surveillance Data 
 
Risk 
Category 
Probability of 
locally acquired 
human disease 
Definition of Risk Category for a Focal Area2 
 Recommended Response 
1 Remote All of the following conditions must be met: 
Prior Year 
No EEE activity detected in a community or focal 
area 
 
And 
Current Year 
No current surveillance findings indicating EEE 
activity in mosquitoes in the focal area                  
 
And 
No animal or human EEE cases. 
 
 
1. MDPH staff provides educational materials and 
clinical specimen submission protocols to targeted 
groups involved in arbovirus surveillance, including, 
but not limited to, local boards of health, physicians, 
veterinarians, animal control officers, and stable 
owners. 
 
2. Educational efforts directed to the general public 
on personal prevention steps and source reduction, 
particularly to those populations at higher risk for 
severe disease (e.g., the elderly). 
 
3. Routine collection and testing of mosquitoes. 
 
4. Assess mosquito populations, monitor larval and 
adult mosquito density.  
 
5. Initiate source reduction; use larvicides at specific 
sites identified by entomologic survey and targeted 
at the likely amplifying bridge vector species. In 
making a decision to use larvicide consider the 
prevalence of Culiseta and bridge vector larvae, 
intensity of prior virus activity, and weather.        
 
6. Locally established, standard, adult mosquito 
control activities are implemented.  No specific 
supplemental control efforts are recommended. 
 
7. Passive human and animal surveillance. 
 
8. Emphasize the need for schools to comply with 
MA requirements for filing outdoor IPM plans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                      
                                                 
2 Focal Area- May incorporate multiple communities, towns or cities, or parts thereof. Factors considered in 
determination of  human risk in a focal area include mosquito habitat, prior isolations, human population densities, 
timing of current isolations of virus in mosquitoes, weather patterns,  time of season conditions needed to present 
risk of human disease  
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2 Low Prior Year 
EEE activity in bird biting mosquitoes only  in the 
prior year in the focal area 
 
Or 
 
Current Year 
1. Sporadic EEE isolations in  Cs. melanura 
mosquito in the community or focal area after 
July 1   
 
And 
 
2. No animal or human cases. 
 
 
Definitions: 
Sporadic EEE activity- when 1-2 mosquito 
isolates are detected during non-consecutive 
weeks within one focal area. 
 
Sustained EEE activity- when mosquito isolates 
are detected for 2 or more consecutive weeks 
within one focal area.  
 
Response as in category 1, plus:  
  
1. Expand community outreach and public education 
programs, particularly among high-risk populations, 
focused on risk potential and personal protection, 
emphasizing source reduction.   
 
2. Increase larval control and source reduction 
measures. 
 
3. Locally established standard adult mosquito 
control activities continue 
 
4. Public health alert sent out by MDPH in response 
to first EEE mosquito isolate detected during the 
season. The alert will summarize current surveillance 
information and emphasize personal prevention 
strategies. 
   
 
 
3 Moderate Prior Year                                                                
Confirmation of one human or animal EEE case 
in the community or focal area; sustained EEE 
activity in bird-biting mosquitoes; or EEE isolate 
from mammal-biting mosquitoes. 
 
Or 
  
Current year                                                             
1. No animal or human EEE cases in current 
year 
 
And 
 
2. A single positive EEE isolate in any mosquito 
species prior to July 1 
 
Or 
 
3. Sustained EEE activity in Cs. melanura after 
July 1 with minimum infection rates that are at or 
below mean levels for focal area trap sites  
                      
 Or 
3. A single EEE isolate from mammal-biting  
mosquitoes (bridge vector species) 
 
Or 
 
4. Sustained EEE activity plus at least one 
multiple meteorological or ecological condition 
(rainfall, temperature, seasonal conditions, or 
larval abundance) associated with elevated 
mosquito abundance and thus likely to increase 
the risk of human disease 
 
   
Response as in category 2, plus: 
 
1. Outreach and public health educational efforts are 
intensified including media alerts as needed. 
 
2. If not already in progress, standard, locally 
established adult mosquito control efforts including 
targeted ground adulticiding operations should be 
considered. The decision to use ground-based adult 
mosquito control will depend on critical modifying 
variables including the time of year, mosquito 
population abundance and proximity of virus activity 
to at-risk populations.  
 
3. Duly authorized local officials may request that the 
DPH Commissioner issue a certification that 
pesticide application is necessary to protect public 
health in order to preempt homeowner private 
property no-spray requests. 
 
4. Supplemental mosquito trapping and testing in 
areas with positive EEE findings.  Notify all boards of 
health of positive findings.   
 
5. Public health alert sent out by MDPH in response 
to first pool of EEE positive mammal-biting 
mosquitoes detected during the season.  The alert 
will summarize current surveillance information and 
emphasize personal prevention strategies. 
6. HHAN (Health and Homeland Alert Network) 
alerts or phone calls are provided to local boards of 
health upon confirmation of EEE in any specimen; 
advise health care facilities of increased risk status 
and corresponding needs to send specimens to SLI 
for testing. 
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4 High Current Year 
1. Sustained or increasing EEE activity in Cs. 
melanura with weekly mosquito minimum 
infection rates above the mean. 
             
Or 
 
2. 2 or more EEE isolates from mammal-biting 
mosquitoes  
 
And/or 
 
3. Sustained or increasing EEE activity in 
mosquitoes plus multiple meteorological or 
ecological conditions (rainfall, temperature, 
seasonal conditions, or larval abundance) 
associated with elevated mosquito abundance 
and thus very likely to increase the risk of human 
disease.   
Response as in category 3, plus:  
 
1. Intensify public education on personal protection 
measures including avoiding outdoor activity during 
peak mosquito hours, wearing appropriate clothing, 
using repellents and source reduction. 
a. Utilize multimedia messages including public 
health alerts from MDPH, press releases from local 
boards of health, local newspaper articles, cable 
channel interviews, etc. 
b.  Encourage local boards of health to actively seek 
out high-risk populations in their communities 
(nursing homes, schools, workers employed in 
outdoor occupations, etc.) and educate them on 
personal protection  
 d.  Advisory information on pesticides provided by 
MDPH Bureau of Environmental Health.                       
e. Urge towns and schools to consider rescheduling 
outdoor, evening events.† 
   
2. Intensify larviciding and/or adulticiding control 
measures where surveillance indicates human risk. 
Local, ground- based ULV applications of adulticide 
may be repeated as necessary to achieve adequate 
mosquito control. Town or city may request 
preemption of homeowner private property no-spray 
requests. 
 
3.  Active surveillance for human cases is intensified. 
Health care facilities are advised of increased risk 
status and corresponding needs to send specimens 
to HSLI for testing. 
4. Local officials should evaluate all quantitative 
indicators including population density and time of 
year and may proceed with focal area aerial 
adulticiding. 
 
5. Duly authorized local officials may request that the 
DPH Commissioner issue a certification that 
pesticide application is necessary to protect public 
health in order to preempt homeowner private 
property no-spray requests. 
 
6. MDPH will confer with local health officials, 
SRMCB and MCPs to determine if the risk of disease 
transmission warrants classification as level 5. 
7. MDPH will confer with local health agencies, 
SRMCB and Mosquito Control Projects to discuss 
the use of intensive mosquito control methods. If 
elevated risk is assessed in multiple jurisdictions and 
evidence exists that risk is likely to either increase 
(based on time of season, weather patterns, etc.) or 
remain persistently elevated, the interventions may 
include state-funded aerial application of mosquito 
adulticide. 
 
 
 
 
† See Appendix 2 for schedule of recommended cancellation time for use 
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5 Critical Current Year 
 
1.  Multiple quantitative measures indicating 
critical risk of human infection (e.g. early season 
positive surveillance indicators, and sustained  
high mosquito infection rates, and horse or 
mammal case indicating escalating epizootic 
activity)   
 
Or 
 
2. A single confirmed EEE human or animal 
case 
 
 
 
 
  
Response as in category 4, plus: 
1. Continued highly intensified public outreach 
messages on personal protective measures. 
Frequent media updates and intensified community 
level education an outreach efforts. Strong 
recommendation for rescheduling of outdoor, 
evening events.† 
2. MDPH will confer with local health agencies, 
SRMCB and Mosquito Control Projects to discuss 
the use of intensive mosquito control methods and 
determine the measures needed to be taken by the 
agencies to allow for and assure that the most 
appropriate mosquito control interventions are 
applied to reduce risk of human infection. These 
interventions may include state-funded aerial 
application of mosquito adulticide. 
 
Factors to be considered in making this decision 
include the seasonal and biological conditions 
needed to present a continuing high risk of EEE 
human disease and that those same conditions 
permit the effective use of an aerially applied 
pesticide. 
 
Once critical human risk has been identified, the 
SRMCB will determine the adulticide activities that 
should be implemented in response to identified risk 
by making recommendations on: 
 
A. Appropriate pesticide 
B. Extent, route and means of treatment 
C. Targeted treatment areas  
  
3. MDPH Bureau of Environmental Health will initiate 
active surveillance via emergency departments and 
with health care provides only if aerial spraying 
commences. 
 
4.  MDPH will designate high-risk areas where 
individual no spray requests may be preempted by 
local and state officials based on this risk level.  If 
this becomes necessary, notification will be given to 
the public.  
 
5. MDPH recommends restriction of group outdoor 
activities, during peak mosquito activity hours, in 
areas of intensive virus activity. 
 
6. MDPH will communicate with health care 
providers in the affected area regarding surveillance 
findings and encourage prompt sample submission 
from all clinically suspect cases. 
 
 
 
 
 
 
 
 
 
 
† See Appendix 2 for schedule of recommended cancellation time for use 
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Appendix 1:  Mosquitoes Associated with Arboviral Activity in Massachusetts 
 
Aedes vexans – Is a common nuisance mosquito. Temporary flooded areas such as woodland pools and 
natural depressions are the preferred larval habitat of this mosquito. It feeds on mammals and is a fierce 
human biter. This species is typically collected from May to October. Ae vexans is an epizootic (bridge) 
vector of eastern equine encephalitis (EEE) virus. 
 
Coquillettidia perturbans - Cattail marshes are the primary larval habitat of this mosquito. It feeds on 
both birds and mammals. It is a persistent human biter and one of the most common mosquitoes in 
Massachusetts. This species is typically collected from June to September. Cq perturbans is an epizootic 
(bridge) vector of EEE virus. 
 
Culex pipiens – Artificial containers are the preferred larval habitat of this mosquito. It feeds mainly on 
birds and occasionally on mammals. It will bite humans, typically from dusk into the evening. This species 
is regularly collected from May to October but can be found year round as it readily overwinters in man-
made structures. Cx pipiens is the primary vector of West Nile Virus (WNV). 
 
Culex restuans – Natural and artificial containers are the preferred larval habitat of this mosquito. It 
feeds almost primarily on birds but has been known to bite humans on occasion. This species is typically 
collected from May to October but can be found year round as it readily overwinters in man-made 
structures.  Cx restuans has been implicated as a vector of WNV.   
 
Culex salinarius – Brackish and freshwater wetlands are the preferred habitat of this mosquito. It feeds 
on birds, mammals, and amphibians and is well known for biting humans. This species is typically 
collected from May to October but can be found year round as it readily overwinters in natural and man-
made structures. Cx salinarius may be involved in the transmission of both WNV and EEE.   
 
Culiseta melanura –White cedar and red maple swamps are the preferred larval habitat of this mosquito. 
It feeds almost exclusively on birds. This species is typically collected from May to October. Cs melanura 
is the primary enzootic vector of EEE.  
 
Ochlerotatus canadensis – Shaded woodland pools are the preferred larval habitat of this mosquito. It 
feeds mainly on birds and mammals but is also known to take blood meals from amphibians and reptiles. 
This mosquito can be a fierce human biter near its  larval habitat. This species is typically collected from 
May to October. Oc canadensis is an epizootic (bridge) vector of eastern equine encephalitis EEE virus. 
 
Ochlerotatus japonicus – Natural and artificial containers such as tires, catch basins, and rock pools are 
the preferred larval habitat of this mosquito. It feeds mainly on mammals and is a fierce human biter. This 
species is typically collected from May to October. Oc japonicus may be involved in the transmission of 
both WNV and EEE. 
 
 
 
 
 
 
 
 
 
 
                    
 
 
 
 
 
                                                                                                                               
 
 
The types of mosquitoes most likely to transmit EEE infection are 
likely to be out searching for food (an animal to bite) at dusk, the 
time period between when the sun sets and it gets completely 
dark (and continue to be active thereafter). The exact timing of 
this increased activity is influenced by many factors including 
temperature, cloud cover, wind and precipitation and cannot 
be predicted precisely for any given day. Here, the approximate 
time of sunset was used to establish standardized 
recommendations for cancellation times of outdoor activities 
during periods of high EEE risk.  
 
This does not eliminate risk nor does it alleviate the 
need for the use of repellants or clothing for 
t ti f it
APPENDIX 2: RECOMMENDED CANCELLATION TIMES FOR OUTDOOR ACTIVITIES IN 
AREAS  
OF HIGH RISK FOR EASTERN EQUINE ENCEPHALITIS (EEE) 
Figure 1:  Location of MDPH EEE  Long-Term Mosquito Trap Sites 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
